Olusesi A D, Hassan S B, Oyeyipo Y, Ukwuije U C, Oyeniran O
Department of Ear, Nose and Throat, National Hospital Abuja, Plot 132, Central Area, Garki (Phase 2), Abuja, 900001, FCT, Nigeria,
Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1383-7. doi: 10.1007/s00405-014-2947-0. Epub 2014 Feb 26.
The objective of this study was to assess the effectiveness of variable titration, low-dose intratympanic gentamycin (ITG) into the worse affected ear of patients with bilateral Meniere's disease (MD). It is a prospective analytic case series conducted in a tertiary care referral hospital in a developing economy and a tertiary care otologic private ENT clinic. Patients with MD who failed or are intolerant to medical treatment were recruited based on the criteria of definite MD and bilateral ear involvement. 0.75 cc of low-dose (40 mg/ml) buffered gentamycin was injected into the worse affected ear and patients followed up every 2 months, and the regime repeated only if subjective vertigo persists. The patient's age, sex, duration of MD symptom, ear first affected, ear selected for ITG, pure tone threshold at each visit, duration of caloric response (in seconds) for the injected ear, status of tinnitus in both ipsilateral (injected) and contralateral ears, total number of injections before last follow-up, and time since last follow-up are entered into the study protocol and analyzed. Nine patients with a mean age of 45 years and mean duration of symptoms of 59 months were treated. The mean total number of injections was 2.8 with a mean follow-up period of 34 months. Three cases showed drop in pure tone average threshold (2.5-7.5 dB) while an increase in threshold was noted in six cases (2.5-5 dB). All cases demonstrated decrease in duration of response to iced water caloric stimulation in ipsilateral ear, and 4/9 of contralateral ear. The variable titration method using low-dose intratympanic gentamycin directed at worse ear of adult Nigerians with bilateral Meniere's disease appears to be highly effective. More studies are needed.
本研究的目的是评估可变滴定法向双侧梅尼埃病(MD)患者受影响更严重的耳朵内注射低剂量鼓室内庆大霉素(ITG)的有效性。这是一项在前瞻性分析病例系列研究,在一个发展中经济体的三级医疗转诊医院和一家三级医疗耳科私立耳鼻喉诊所进行。根据明确的MD和双耳受累标准,招募了对药物治疗无效或不耐受的MD患者。将0.75 cc低剂量(40 mg/ml)缓冲庆大霉素注入受影响更严重的耳朵,患者每2个月随访一次,仅当主观眩晕持续时才重复该方案。将患者的年龄、性别、MD症状持续时间、首次受影响的耳朵、选择用于ITG治疗的耳朵、每次就诊时的纯音阈值、注射耳朵的冷热反应持续时间(以秒为单位)、同侧(注射)和对侧耳朵的耳鸣状态、最后一次随访前的注射总数以及自上次随访以来的时间纳入研究方案并进行分析。治疗了9名平均年龄为45岁、平均症状持续时间为59个月的患者。平均注射总数为2.8次,平均随访期为34个月。3例患者的纯音平均阈值下降(2.5 - 7.5 dB),而6例患者的阈值升高(2.5 - 5 dB)。所有病例同侧耳朵对冰水冷热刺激的反应持续时间均缩短,对侧耳朵中有4/9的病例也是如此。对于成年尼日利亚双侧梅尼埃病患者,使用低剂量鼓室内庆大霉素针对受影响更严重耳朵的可变滴定法似乎非常有效。还需要更多研究。